L'Helias Sophie purchased $14K of HLF

L'Helias Sophie purchased 1,200 shares of HERBALIFE LTD. (HLF) at $11.31 on 2026-06-04.

Original reporting
SEC EDGAR · L'Helias Sophie
Published Jun 4, 2026, 10:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HLF
Neutral
medium confidence
Mentioned
$HLF
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HLFNeutralLow
01

Why it matters

This provides a fresh datapoint on insider behavior but does not introduce new company fundamentals (no guidance, financial results, or deal terms).

02

Market read

Traders may note the buy as a minor bullish sentiment input, but it is unlikely to be a standalone driver of price action.

03

What to watch

Transaction size is small and lacks accompanying narrative; without follow-on buys or operational news, signal-to-noise is low.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed today (2026-06-04)

Background

The article is an SEC insider transaction disclosure (Form 4) showing a director’s open-market purchase of HLF shares.

Company-level read

Ticker impact

$HLFNeutralMedium confidence
Context

Director L'Helias Sophie bought 1,200 shares of Herbalife (HLF) in an open-market transaction disclosed via SEC Form 4 on 2026-06-04.

Expected impact

Limited near-term impact; any effect is likely short-lived unless followed by additional buying or company-specific news.

Evidence & confidence

The filing is an insider transaction (not earnings/guidance/M&A). The disclosed size (~$13.6k) is relatively small, and there is no 10b5-1 plan pre-arrangement noted, but insider buys alone rarely drive sustained repricing.

Market effects

Minimal; this is company-specific insider activity with no stated sector/regulatory trigger.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine diversification or personal liquidity decisions and may not reflect a change in business outlook.

Key entities

  • HERBALIFE LTD.

    Public company whose director disclosed an open-market purchase of shares via SEC Form 4.

  • L'Helias Sophie

    Director who purchased 1,200 shares of HLF at $11.31/share on 2026-06-04.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HLFMedAI 8/10

Herbalife Ltd (HLF) (Q3 2026) Earnings Call Highlights: Fifth Straight Quarter

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, beating guidance. Growth was driven by India and nutrition clubs, while EMEA and China saw declines. The company raised full-year sales guidance but expects gradual margin expansion. Interim CEO John DeSimone discussed product repositioning and new technology platforms. Operating cash flow rose 27% YoY, and net leverage improved to 2.0x.

$HLFHighAI 8/10

Why Herbalife Stock Is Up Today

Herbalife (HLF) shares rose 8% after Q3 results showed 6% revenue growth to $1.35B, with Asia Pacific up 18%. Adjusted net income increased 33% to $68.5M. The company raised full-year sales guidance and announced a $250M stock buyback program. According to interim CEO John DeSimone, growth is driven by 3M+ independent distributors.

$HLFMedAI 8/10

Herbalife Reports Q3 2026 Financial Results

Herbalife Ltd. reported Q3 2026 net sales of $1.35B, up 6% YoY, with regional growth varying. Adjusted EBITDA was $182.4M, EPS $0.55. Gross margin slightly declined to 77.3%. The company cited refinancing benefits and debt reduction. Management expects continued net sales growth.

$HLFHighAI 8/10

Herbalife (HLF) Q3 2026 Earnings Call Transcript

Herbalife (HLF) reported Q3 2026 net sales of $1.4B, up 6% YoY, and adjusted EBITDA of $182M, exceeding guidance. Interim CEO John DeSimone highlighted growth opportunities, including strengthening Nutrition Clubs and expanding the Bioniq brand. The company aims to enhance distributor support and technology capabilities.

$HLFMedAI 8/10

What Herbalife (HLF) Said on Its Q3 Earnings Call

Herbalife (HLF) reported Q3 sales growth of 5.1% in constant currency and 9% reported, with North America up 1.7%. FX reduced net sales by $21M. The company outlined priorities: nutrition clubs, tech platforms, and Bioniq brand growth. It expects Q4 sales growth of 0.5% to 4.5% and raised full-year sales guidance to 4.9% to 5.9%. Operating cash flow rose 27% YoY to $298M.